ramelteon has been researched along with edaravone in 1 studies
Studies (ramelteon) | Trials (ramelteon) | Recent Studies (post-2010) (ramelteon) | Studies (edaravone) | Trials (edaravone) | Recent Studies (post-2010) (edaravone) |
---|---|---|---|---|---|
317 | 59 | 204 | 1,128 | 69 | 668 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahsan, A; Cao, M; Chen, JZ; Chen, Z; Hu, WW; Jiang, L; Liu, MR; Lu, SS; Tang, WD; Wu, JY; Wu, XL; Zhang, XN; Zheng, YR | 1 |
1 other study(ies) available for ramelteon and edaravone
Article | Year |
---|---|
Melatonin receptor agonist ramelteon attenuates mouse acute and chronic ischemic brain injury.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Brain; Brain Injury, Chronic; Edaravone; Indenes; Infarction, Middle Cerebral Artery; Mice; Neuroprotective Agents; Receptors, Melatonin; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |